Arnaud Bayle

469 total citations
16 papers, 160 citations indexed

About

Arnaud Bayle is a scholar working on Oncology, Cancer Research and Economics and Econometrics. According to data from OpenAlex, Arnaud Bayle has authored 16 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cancer Research and 5 papers in Economics and Econometrics. Recurrent topics in Arnaud Bayle's work include Cancer Genomics and Diagnostics (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Arnaud Bayle is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Arnaud Bayle collaborates with scholars based in France, United States and Canada. Arnaud Bayle's co-authors include Benjamin Besse, Julia Bonastre, Maxime Annereau, Sylvain Rubin, B Baehrel, Florian Scotté, Francesca Lucibello, Pierre Loulergue, Ali N. Chamseddine and Olivier Mir and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Arnaud Bayle

15 papers receiving 158 citations

Peers

Arnaud Bayle

ONCOL

PRM

SURGE

Anath Flugelman Israel

Claudia Brusadelli Italy

Gabriela Sousa Portugal

Mona Shafey Canada

Omar Al Omari United States

Matthew Smeltzer United States

Fauzia Riaz United States

Sergey Efetov Russia

Nicholas H. Chakiryan United States

Anath Flugelman Israel

Arnaud Bayle

118 ×1.5

ONCOL

41 ×0.8

PRM

12 ×0.4

5 ×0.2

21 ×1.0

SURGE

Citations per year, relative to Arnaud Bayle Arnaud Bayle (= 1×) peers Anath Flugelman

Countries citing papers authored by Arnaud Bayle

Since Specialization

Citations

This map shows the geographic impact of Arnaud Bayle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bayle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bayle more than expected).

Fields of papers citing papers by Arnaud Bayle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bayle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bayle. The network helps show where Arnaud Bayle may publish in the future.

Co-authorship network of co-authors of Arnaud Bayle

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bayle. A scholar is included among the top collaborators of Arnaud Bayle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bayle. Arnaud Bayle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Italiano, Antoine, Jakob Dupont, Tarek Assi, et al.. (2025). The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. European Journal of Cancer. 226. 115609–115609. 1 indexed citations

Blanc‐Durand, Félix, Géraldine M. Camilleri, Arnaud Bayle, et al.. (2024). Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer. Cancer. 130(19). 3311–3320. 1 indexed citations

Bayle, Arnaud, Sophie Cousin, Etienne Rouleau, et al.. (2024). Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials. npj Precision Oncology. 8(1). 227–227. 1 indexed citations

Blin, Olivier, Arnaud Bayle, Christophe Le Tourneau, et al.. (2023). Comment faire entrer la médecine de précision dans la décision thérapeutique de routine au lit du malade ?. Therapies. 79(1). 1–11.

Smolenschi, Cristina, Antoine Hollebecque, Alice Boilève, et al.. (2023). PD-29 Could molecular profiling be helpful in daily practice in the treatment of anal carcinoma?. Annals of Oncology. 34. S13–S13. 1 indexed citations

Dare, Anna, et al.. (2023). Ensuring Global Access to Cancer Medicines: A Generational Call to Action. Cancer Discovery. 13(2). 269–274. 3 indexed citations

Jenei, Kristina, Adam Raymakers, Arnaud Bayle, et al.. (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study. The Lancet Oncology. 24(6). 624–635. 25 indexed citations

Blin, Olivier, Arnaud Bayle, Christophe Le Tourneau, et al.. (2023). Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?. Therapies. 79(1). 13–22. 1 indexed citations

Bayle, Arnaud, et al.. (2023). Coût des technologies de séquençage haut débit (NGS) : revue de la littérature et enseignements. Bulletin du Cancer. 111(2). 190–198. 4 indexed citations

10.

Cousin, Sophie, Arnaud Bayle, Etienne Rouleau, et al.. (2023). Tumor fraction to improve patient selection for oncology early phase clinical trials: Analysis of two precision medicine studies.. Journal of Clinical Oncology. 41(16_suppl). 3005–3005. 1 indexed citations

11.

Tougeron, David, Laurent Villeneuve, Clarisse Eveno, et al.. (2022). Immune checkpoint inhibitors for patients with isolated peritoneal carcinomatosis from dMMR/MSI-H colorectal cancer, a BIG-RENAPE collaboration. Digestive and Liver Disease. 55(5). 673–678. 8 indexed citations

12.

Bayle, Arnaud, Nathalie Droin, Benjamin Besse, et al.. (2021). Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting. The European Journal of Health Economics. 22(6). 855–864. 10 indexed citations

13.

Bayle, Arnaud, Mohamed Khettab, Francesca Lucibello, et al.. (2020). Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1. Annals of Oncology. 31(7). 959–961. 26 indexed citations

14.

Barlési, Fabrice, Stéphanie Foulon, Arnaud Bayle, et al.. (2020). Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments. Cancer Research. 80(16_Supplement). CT403–CT403. 22 indexed citations

15.

Bayle, Arnaud, Benjamin Besse, Maxime Annereau, & Julia Bonastre. (2019). Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?. European Journal of Cancer. 113. 28–31. 28 indexed citations

16.

Rubin, Sylvain, et al.. (2006). Retrograde aortic dissection after a stent graft repair of a type B dissection: how to improve the endovascular technique. Interactive Cardiovascular and Thoracic Surgery. 5(6). 746–748. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact